Search bioRxiv⌕ Search

Biology subjects

Gunnarsson, C.

Publications and source records attributed to Gunnarsson, C..

2 recordsLinked to original sources

Bacterial surface display enables lysis-independent joint host-pathogen single-cell profiling

Heterogeneity in host-pathogen interactions arises from variation in both host cell state and pathogen state, yet most single-cell methods capture these features separately. Joint profiling is limited by fundamental technical mismatches between host- and pathogen-derived material, particularly differences in cell wall structure, lysis requirements, and molecular abundance. Here we introduce a lysis-independent strategy that enables unified measurement of intracellular bacterial presence and state alongside host single-cell profiles. We repurpose bacterial surface display to encode promoter activity and bacterial identity as antibody-detectable signals, rendering bacterial features compatible with existing antibody-based single-cell assays. This approach is modular across promoters, epitope tags, display scaffolds, and bacterial species, including Escherichia coli and Mycobacterium tuberculosis. Surface-displayed reporters are detectable during intracellular infection and can be read out by flow cytometry and droplet-based single-cell RNA sequencing without pathogen-specific lysis optimization or pre-sorting on pathogen signal. Applying this method to infected macrophages, we link heterogeneous bacterial uptake to heterogeneous expression of phagocytosis-associated host programs. This strategy enables scalable, joint host-pathogen single-cell measurements and expands the range of pathogens and states accessible to high-throughput single-cell analysis.

bioengineering↗

Systems-level characterization of EGFR kinase inhibitors reveals heterogeneous effects on Mtb-macrophage interactions

Mycobacterium tuberculosis (Mtb) causes deadly, antibiotic-recalcitrant disease. Host-directed therapy (HDT) is a proposed, antibiotic-complementary approach that enhances host antimicrobial function, thereby restricting intracellular Mtb. Drug repurposing screens suggest that inhibiting epidermal growth factor receptor (EGFR) may improve macrophage restriction of Mtb. However, the role of EGFR in restriction is not well understood. We show EGFR kinase inhibitors are not generally Mtb-restrictive in human monocyte-derived macrophages. Few EGFR inhibitors restrict intracellular Mtb and do so via heterogeneous mechanisms, including direct antibiotic effects and host-dependent, likely EGFR-independent mechanisms. During host-dependent therapy, intracellular Mtb induce defined, stress-responsive gene modules, with each drug inducing a unique combination of restriction-associated stresses. We decompose intracellular Mtb responses into host-dependent contributions and host-independent contributions suggestive of direct drug-Mtb interaction. Together, our data nuances the host-directed model of EGFR inhibitors for tuberculosis and provides a roadmap for systematically characterizing repurposed drugs from multiple angles of the drug-host-pathogen interaction.

systems biology↗